Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

3 clinical studies listed.

Filters:

End Stage Chronic Renal Failure

Tundra lists 3 End Stage Chronic Renal Failure clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

RECRUITING

NCT07385651

Deceased Donor Kidney Storage at 10 Celsius Versus Conventional Storage

The goal of this clinical trial is to test how storage temperature of deceased donor kidneys affects kidney function after transplant in adult patients receiving a kidney transplant. The main question it aims to answer is: • Do patients that receive a kidney transplant stored at 10 °C have improved post-transplant kidney function? Researchers will compare patients who receive kidneys stored at 10 °C versus kidneys stored at 4°C (on ice, i.e. conventional storage) to see if kidneys stored at 10 °C have improved function. Participants will: * Be made aware of and consent to receive a kidney transplant that had been stored at 10 °C * Have their urine collected 24 hours after surgery to be analyzed for research

Gender: All

Ages: 18 Years - Any

Updated: 2026-04-06

1 state

End Stage Chronic Renal Failure
Chronic Kidney Disease (Stages 4 and 5)
Kidney Transplantation Recipients
RECRUITING

NCT07491042

Impact of SGLT2 Inhibitors on Chronic Peritoneal Dialysis Patients.

This project aims to examine the effects of six-month treatment with selective SGLT2 inhibitor dapagliflozin in patients with end-stage kidney disease on chronic peritoneal dialysis. Methods: A prospective, open label, single-arm interventional clinical trial, will conduct at Nizwa Hospital from March 1st, 2026, to August 31th , 2026, and includes thirty (30) end-stage kidney disease diabetic and non-diabetic patients on chronic peritoneal dialysis, will receive selective SGLT2i Dapagliflozin 10 mg once daily (OD). Clinical and laboratory parameters will be assessed at baseline, then three and six months after drug initiation. The primary outcomes are:1- change in ultrafiltration volume, 2- change in Kt/V (dialysis adequacy), 3. Change in the mean 24-hour urine volume.

Gender: All

Ages: 13 Years - Any

Updated: 2026-03-24

End Stage Chronic Renal Failure
NOT YET RECRUITING

NCT07428395

Feasibility of Intradialytic Monitoring During CKRT

This is a pilot observational cohort study to understand whether advanced monitoring techniques can be applied during continuous kidney replacement therapy (CKRT), which is the most common form of dialytic therapy provided in critically ill patients.

Gender: All

Ages: 18 Years - Any

Updated: 2026-02-24

Acute Kidney Injury
End Stage Chronic Renal Failure
Dialysis